Verified Nov 2026
Other
·
San Diego, California
·
Since 1998
Illumina is a biotechnology company headquartered in San Diego, California, founded in 1998. It develops DNA sequencing and array-based technologies, including sequencing systems, consumables, and microarray solutions for genotyping and gene expression. The company is publicly traded under the ticker ILMN, employs roughly 5,000 to 10,000 people, and reported revenue of about $4.34 billion in 2025. Its products serve research, clinical, and applied markets, including clinical diagnostics such as the Galleri early cancer detection test.
Illumina at a glance
Revenue
4.3B
Employees
5,000-10,000
Founded
1998
Headquarters
San Diego, California
Ownership
Publicly traded (NASDAQ: ILMN)
Import activity
939
Industries
Automotive
Electric Vehicles
Medical
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
939
Named foreign suppliers
23
Top origins
Singapore · China · Vietnam · Malaysia
Shared foreign counterparties do not establish that these companies buy from Illumina.
What this tells a buyer
The record does not include customs or trade shipment data for the company, and it lists no recent developments.
Its offerings include integrated sequencing systems, DNA, RNA, and protein analysis consumables, microarray genotyping solutions, and clinical diagnostics such as the Galleri test and noninvasive prenatal testing.
The company is publicly listed on the stock exchange under the ticker ILMN and reports serving customers in over 155 countries.
Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026
Overview
Illumina is a biotechnology company headquartered in San Diego, California, founded in 1998. It develops DNA sequencing and array-based technologies, including sequencing systems, consumables, and microarray solutions for genotyping and gene expression. The company is publicly traded under the ticker ILMN, employs roughly 5,000 to 10,000 people, and reported revenue of about $4.34 billion in 2025. Its products serve research, clinical, and applied markets, including clinical diagnostics such as the Galleri early cancer detection test.
At a glance
Attribute | Detail |
|---|---|
Founded | 1998 |
Headquarters | San Diego, California |
Employees | 5,000-10,000 |
Revenue | 4.3B |
Ownership | Publicly traded (NASDAQ: ILMN) |
What Illumina makes
Its offerings include integrated sequencing systems, DNA, RNA, and protein analysis consumables, microarray genotyping solutions, and clinical diagnostics such as the Galleri test and noninvasive prenatal testing.
Trade and customs footprint
The record does not include customs or trade shipment data for the company, and it lists no recent developments. US customs bill-of-lading records list 939 inbound shipments across 23 foreign suppliers, with top origins including Singapore · China · Vietnam · Malaysia.
Company details
The company is publicly listed on the stock exchange under the ticker ILMN and reports serving customers in over 155 countries. Illumina was founded in 1998, has an estimated 5,000-10,000 employees, and is headquartered in San Diego, California.
Frequently asked questions
What does Illumina do?
Illumina is a biotechnology company headquartered in San Diego, California, founded in 1998. It develops DNA sequencing and array-based technologies, including sequencing systems, consumables, and microarray solutions for genotyping and gene expression. The company is publicly traded under the ticker ILMN, employs roughly 5,000 to 10,000 people, and reported revenue of about $4.34 billion in 2025. Its products serve research, clinical, and applied markets, including clinical diagnostics such as the Galleri early cancer detection test.
Where is Illumina headquartered?
Illumina is headquartered in San Diego, California (5200 Illumina Way, San Diego, California, 92122).
When was Illumina founded?
Illumina was founded in 1998.
How big is Illumina?
Illumina has an estimated 5,000-10,000 employees, with revenue in the 4.3B range.
Is Illumina publicly traded?
Publicly traded (NASDAQ: ILMN). Public financial figures are drawn from its filings.
Does Illumina import from overseas suppliers?
US customs bill-of-lading records show 939 inbound shipments for Illumina, with top origins including Singapore · China · Vietnam · Malaysia.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.